Theophylline for acute renal vasoconstriction associated with tacrolimus: a new indication for an old therapeutic agent?
Thomas
Neal J
NJ
Carcillo
Joseph A
JA
D000628:Aminophylline / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D065095:Calcineurin Inhibitors; D002648:Child; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use / Q000633:toxicity*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D015278:Intensive Care Units, Pediatric; D007668:Kidney / Q000187:drug effects*; D016377:Organ Transplantation; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D058915:Purinergic P1 Receptor Antagonists; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects; D016559:Tacrolimus / Q000627:therapeutic use / Q000633:toxicity*; D013806:Theophylline / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D014661:Vasoconstriction / Q000187:drug effects*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D010726:Phosphodiesterase Inhibitors; D058915:Purinergic P1 Receptor Antagonists; D000628:Aminophylline; D013806:Theophylline; D016559:Tacrolimus